Derek L. Lee

Hong Kong Science Park
Hong Kong, HCW, Hong Kong Special Administrative Region

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Primary Prevention of Cardiovascular Disease in Asia: Challenges: A Narrative Review.

Primary Prevention of Cardiovascular Disease in Asia: Challenges: A Narrative Review.

Journal: JACC. Advances

Published: December 19, 2024

BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinoma.

BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinoma.

Journal: Cell reports. Medicine

Published: September 06, 2024

Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modification.

Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modification.

Journal: Journal of hepatology

Published: August 16, 2024

Humoral and Cellular Immunogenicity and Safety of 3-Dose Inactivated COVID-19 Vaccine in Young Children Less Than 5 Years With Kidney Diseases.

Humoral and Cellular Immunogenicity and Safety of 3-Dose Inactivated COVID-19 Vaccine in Young Children Less Than 5 Years With Kidney Diseases.

Journal: Kidney international reports

Published: April 13, 2023

Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney Diseases.

Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney Diseases.

Journal: Kidney international reports

Published: January 30, 2023

COVID-19 vaccines versus pediatric hospitalization.

COVID-19 vaccines versus pediatric hospitalization.

Journal: Cell reports. Medicine

Published: September 10, 2022

Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents.

Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents.

Journal: Signal transduction and targeted therapy

Published: August 14, 2022

CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma.

CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 01, 2022

Genome-Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment.

Genome-Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 11, 2022

Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.

Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.

Journal: Cellular and molecular gastroenterology and hepatology

Published: February 04, 2022

Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity.

Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity.

Journal: Hepatology (Baltimore, Md.)

Published: August 30, 2021

Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses.

Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses.

Journal: Journal of hepatology

Published: April 11, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026